One product, Humate-P, has been approved by the FDA for use in patients with von Willebrand disease. There is also a vWF product manufactured in France that is currently in U.S. clinical trials sponsored by the American Red Cross. I, a protein in the blood that is converted to fibrin by the action of thrombin. These mutations occur during egg cell development and are not found in the woman's other cells, such as blood cells. These products vary in the amount of factor they contain.
Proteins occur in all animal and vegetable matter and are necessary for growth and repair.
Recombinate is also distributed under the trade name Bioclate, and Kogenate is distributed as well under the name Helixate. No human serum proteins are used in its production or formulation. Alphanate and Koate DVI are solvent-detergent treated using TNBP and Polysorbate 80. The information contained on the NHF web site is provided for your general information only. NHF does not give medical advice or engage in the practice of medicine.